Search - tctmd.com

Displaying 561 - 580 of 994

Sort: Relevancy | Date

Presentation TCT 2019

TCT 78: Transcatheter Aortic Valve Replacement in Patients With Large and Extra-Large Aortic Annuli: Hemodynamic Performance of New Generation Balloon- and Self-Expandable Aortic Valves.

Presenter: Luis Nombela-Franco

September 25, 2019

Presentation TCT 2019

TCT 77: Transcarotid Versus Subclavian/Axillary Access for Transcatheter Aortic Valve Replacement: Real World Comparative Outcomes Utilizing the TVT Registry

Presenter: James Hermiller

September 25, 2019

Presentation TCT 2019

TCT 79: Multimodality Assessment of Prosthetic Valve Regurgitation to Predict Reverse Cardiac Remodeling and Long-term Clinical Outcomes after Transcatheter Aortic Valve Replacement Results From the Prospective POST-TAVI Registry

Presenter: Mohammad Abdelghani

September 25, 2019

Presentation TCT 2019

TCT 76: Mid-term Outcomes after Transcatheter Aortic Valve Replacement with a Mechanically-expanded versus Self-Expandable Valve: 3-year Results from the REPRISE III Randomized Trial

Presenter: David Rizik

September 25, 2019

Presentation TCT 2019

TCT 75: Infective Endocarditis After Transcatheter Aortic Valve Replacement: Findings From a UK Nationwide Linkage Study

Presenter: Tom Cahill

September 25, 2019

Presentation TCT 2019

TCT 74: Baseline Left Ventricular Hypertrophy and Five Year Outcomes after Transcatheter Aortic Valve Replacement: An Analysis of the PARTNER Trials and Registries

Presenter: Holly Gonzales

September 25, 2019

Presentation TCT 2019

TCT 36: Clinical Predictors of Hypo-Attenuated Leaflet Thickening Following Transcatheter Aortic Valve Replacement with 320-Multislice Scanner: A Single Center Experience.

Presenter: Hashrul Rashid

September 25, 2019

Presentation TCT 2019

TCT 35: Redo Transcatheter Aortic Valve Replacement for Structural and Non-Structural Transcatheter Valve Dysfunction: Initial Experience From a Single High-Volume Center

Presenter: Lisa Crusius

September 25, 2019

$TCT 33: Bioprosthetic valve fracture performed pre versus post valve-in-valve transcatheter aortic valve replacement: Insights from bench testing$

Presentation TCT 2019

TCT 33: Bioprosthetic valve fracture performed pre versus post valve-in-valve transcatheter aortic valve replacement: Insights from bench testing

Presenter: Janarthanan Sathananthan, MD

September 25, 2019

News Daily News

Early Signs Positive for Tendyne TMVR in Severe MAC

Caitlin E. Cox

September 11, 2019

News Daily News

VA Medical Centers’ Quality Measures for TAVR Pay Off

Caitlin E. Cox

August 30, 2019

News Daily News

MIDAS Touch: Anatomic Strategy Dramatically Lowers Pacemaker Rate With Evolut Valves

Michael O'Riordan

August 29, 2019

News Daily News

Aborted TAVR Procedures Are Waning in the US

Shelley Wood

August 28, 2019

News Daily News

FDA Expands TAVR Indication to Low-Risk Patients

Michael O'Riordan

August 16, 2019

News Industry News

Medtronic Evolut TAVR System Receives Expanded Indication to Treat Symptomatic Severe Aortic Stenosis Patients at Low Risk for Surgical Mortality

August 16, 2019

News Daily News

Better Outcomes, Fewer Complications Among Higher-Volume MitraClip Sites

Michael O'Riordan

July 17, 2019

News Daily News

Evolut Valves: Initial Positioning Can Be Optimized for Future Coronary Access

Michael O'Riordan

July 10, 2019

News Conference News TVT 2019

Better Hemodynamics, Less Mismatch With Self-Expanding TAVR vs Surgery

Michael O'Riordan

June 20, 2019

Presentation TVT 2019

Functional Status After Transcatheter and Surgical Aortic Valve Replacement: A Two-Year Analysis From the SURTAVI Trial

Presenter: Mark Tuttle

June 15, 2019

Presentation TVT 2019

Echocardiographic Results of Transcatheter Versus Surgical Aortic Valve Replacement in Low-Risk Patients: The PARTNER 3 Trial

Presenter: Philippe Pibarot

June 14, 2019

Advertisement

TCT 78: Transcatheter Aortic Valve Replacement in Patients With Large and Extra-Large Aortic Annuli: Hemodynamic Performance of New Generation Balloon- and Self-Expandable Aortic Valves.

TCT 77: Transcarotid Versus Subclavian/Axillary Access for Transcatheter Aortic Valve Replacement: Real World Comparative Outcomes Utilizing the TVT Registry

TCT 79: Multimodality Assessment of Prosthetic Valve Regurgitation to Predict Reverse Cardiac Remodeling and Long-term Clinical Outcomes after Transcatheter Aortic Valve Replacement Results From the Prospective POST-TAVI Registry

TCT 76: Mid-term Outcomes after Transcatheter Aortic Valve Replacement with a Mechanically-expanded versus Self-Expandable Valve: 3-year Results from the REPRISE III Randomized Trial

TCT 75: Infective Endocarditis After Transcatheter Aortic Valve Replacement: Findings From a UK Nationwide Linkage Study

TCT 74: Baseline Left Ventricular Hypertrophy and Five Year Outcomes after Transcatheter Aortic Valve Replacement: An Analysis of the PARTNER Trials and Registries

TCT 36: Clinical Predictors of Hypo-Attenuated Leaflet Thickening Following Transcatheter Aortic Valve Replacement with 320-Multislice Scanner: A Single Center Experience.

TCT 35: Redo Transcatheter Aortic Valve Replacement for Structural and Non-Structural Transcatheter Valve Dysfunction: Initial Experience From a Single High-Volume Center

TCT 33: Bioprosthetic valve fracture performed pre versus post valve-in-valve transcatheter aortic valve replacement: Insights from bench testing

Early Signs Positive for Tendyne TMVR in Severe MAC

VA Medical Centers’ Quality Measures for TAVR Pay Off

MIDAS Touch: Anatomic Strategy Dramatically Lowers Pacemaker Rate With Evolut Valves

Aborted TAVR Procedures Are Waning in the US

FDA Expands TAVR Indication to Low-Risk Patients

Medtronic Evolut TAVR System Receives Expanded Indication to Treat Symptomatic Severe Aortic Stenosis Patients at Low Risk for Surgical Mortality

Better Outcomes, Fewer Complications Among Higher-Volume MitraClip Sites

Evolut Valves: Initial Positioning Can Be Optimized for Future Coronary Access

Better Hemodynamics, Less Mismatch With Self-Expanding TAVR vs Surgery

Functional Status After Transcatheter and Surgical Aortic Valve Replacement: A Two-Year Analysis From the SURTAVI Trial

Echocardiographic Results of Transcatheter Versus Surgical Aortic Valve Replacement in Low-Risk Patients: The PARTNER 3 Trial

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content